Stocks and Investing
Stocks and Investing
Fri, June 26, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 25, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Geoff Meacham Initiated (BBIO) at Hold and Held Target at $38 on, Jun 25th, 2020
Geoff Meacham of B of A Securities, Initiated "BridgeBio Pharma, Inc." (BBIO) at Hold and Held Target at $38 on, Jun 25th, 2020.
Geoff has made no other calls on BBIO in the last 4 months.
There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Geoff's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Geoff
- Mani Foroohar of "SVB Leerink" Reiterated at Buy with Decreased Target to $39 on, Thursday, May 14th, 2020
- Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $50 on, Monday, April 13th, 2020
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $43 on, Tuesday, March 3rd, 2020